Selina M. Luger, MD, FRCPC

home / authors / selina-m-luger-md-frcpc

Articles

Women in Oncology: Prioritization and Passionate Legacies

Catherine E. Lai, MD, MPH;Selina M. Luger, MD, FRCPC;Gail J. Roboz, MD ;Wendy Stock, MD

August 30th 2022

Selina M. Luger, MD, FRCPC, Gail J. Roboz, MD, and Wendy Stock, MD, discuss how being female affected their careers and share the scientific achievements they most want to be remembered for in the leukemia field.

Women in Oncology: Resilience That Leads to Innovation

Catherine Lai, MD, MPH, ;Selina M. Luger, MD, FRCPC;Gail J. Roboz, MD ;Wendy Stock, MD

August 23rd 2022

Selina M. Luger, MD, FRCPC; Gail J. Roboz, MD; and Wendy Stock, MD, discuss how they turned their leukemia career “lemons” into “lemonade.”

Women in Oncology: Bringing Advances From the Lab Into the Clinic

Catherine E. Lai, MD, MPH;Selina M. Luger, MD, FRCPC;Gail J. Roboz, MD ;Wendy Stock, MD

August 19th 2022

Selina M. Luger, MD, FRCPC; Gail J. Roboz, MD; and Wendy Stock, MD, discuss what motivated them to continue working toward improvements in the leukemia field, even when outcomes were dismal and treatment options were scarce.

Women in Oncology: How Early Treatments Paved the Way for Future Advances

Catherine E. Lai, MD, MPH;Selina M. Luger, MD, FRCPC;Gail J. Roboz, MD ;Wendy Stock, MD

August 18th 2022

Selina M. Luger, MD, FRCPC; Gail J. Roboz, MD; and Wendy Stock, MD, discuss the challenges that accompanied the lack of progress in leukemia treatment when they began their fellowships and express their excitement about encouraging developments that have since emerged in the arena.